Periwinkle Extract and increase blood flow in the brain ...

old message the effect of vinpocetine on cerebral blood flow (CBF) ... Darrell Miller 05/26/05

PreviousNextListen To An Article On the effect of vinpocetine on cerebral blood flow (CBF) ...

Date: May 26, 2005 10:37 AM
Subject: the effect of vinpocetine on cerebral blood flow (CBF) ...

Abstract Objectie :To investigate the effect of vinpocetine on cerebral blood flow (CBF) in the compromised circulation of a stroke affected hemisphere using transcranial Doppler (TCD) and near infrared spectroscopy (NIRS) methods. Methods : 43 patients with ischemic stroke were randomized into vinpocetine (VP) and placebo group in a double blind, placebo-controlled study of the effect of a single-dose i.v. infusion of vinpocetine on cerebral blood perfusion and oxygenation. In the VP group 20 mg VP in 500 ml saline, in the placebo group 500 ml saline alone were administered. The concentrations of oxy-, reduced- and total hemoglobin were measured by NIRS frontolaterally on the side of lesion while the mean cerebral blood flow velocity (CBFV), the pulsatility index (PI) and Doppler spectral intensity (DSI) were monitored by TCD in the middle cerebral artery on the same side. Values were averaged for the first 5 min prior to the infusion and for the last 5 min of infusion and they were compared between groups. Results : The concentration of all three chromophores increased during infusion in the VP group (mean dHbT=1.03, CI95=0.84, P=0.058; mean dHbO=0.92, CI95=0.91, P=0.071; mean dHb=0.10, CI95=0.21, P=0.297). The HbT and HbO showed a substantially smaller increase in the placebo group (mean dHbT=0.31, CI95=0.74, P=0.22; mean dHbO=0.57, CI95=0.80, P=0.094) while the Hb decreased (mean dHb=-0.26, CI95=0.29, P=0.05). Comparing to the placebo group Hb increased significantly in the VP group (P=0.027) while the increase of HbO and HbT did not reach the level of significance (P=0.29 and 0.11). DSI showed a significantly larger increase in the VP than in placebo group (dDSI=25.8 CI95=8.8 [VP]; dDSI=3.3, CI95=3.7 [Placebo], P0.005). The CBFV and PI did not differ significantly between groups. (dVm=5.02.98 cm/s [VP], dVm=4.12.57 cm/s [Placebo], P=0.28; dPI=0.08 [VP], dPI=0.09 [Placebo]; P=0.47). Conclusion :VP increases cerebral perfusion and parenchymal oxygen extraction as well. The increased perfusion was indicated by NIRS and by TCD measurement of DSI while conventional velocity and pulsatility measurements failed to detect theses effects. NIRS is a sensitive, Abbreiations :BP, blood pressure; CI, confidence interval; CBFV, cerebral blood flow velocity; CT, computer tomography; CytO, cytochrome-oxydase; DSI, Doppler spectral intensity; Hb, deoxyhaemoglobin; HbO, oxyhaemoglobin; HbT, total haemoglobin; HR, heart rate; MAP, mean arterial pressure; MCA, middle cerebral artery; MRI, magnetic resonance imaging; NIRS, near infrared spectroscopy; PET, positron emission tomography; PI, pulsatility index; TCD, transcranial Doppler; US, ultrasonography; VP, vinpocetine.

  • Doppler spectral intensity (DSI) - scans the brain and you can see blood flow.
  • DSI increased in both groups during infusion, however, the increase was significantly higher in the vinpocetine group (dDSI=25.8, CI95=8.8 [VP]; dDSI=3.3, CI95=3.7 [placebo] -- Significant increase in blood flow 25.8 (VP) vs. 3.3 (Placebo)
  • NIRS monitoring is feasible to detect changes of regional blood flow and tissue oxygenation.
  • The observation reported VP to enhance cerebral oxygen extraction and utilisation

  • --
    VitaNet ® Staff

    Guarantee: VitaNet® LLC Offers a 100% Satisfaction Guaranteed!

    VitaNet ® LLC. Discount Vitamin Store.